Used in pharmaceutical research as a key intermediate in the synthesis of selective receptor modulators, particularly for central nervous system targets. Its structure supports high binding affinity and selectivity, making it valuable in developing potential treatments for neurological and psychiatric disorders such as depression, anxiety, and chronic pain. The compound's fluorinated alkoxy groups enhance metabolic stability and membrane permeability, which are advantageous for drug candidates targeting the brain. It is also employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties in novel therapeutics.